hydroxyindoleacetic acid has been researched along with Hallucinations in 14 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the patient group with visual hallucinations, mean salsolinol level was significantly increased to almost the 3-fold of those found in patients without hallucinations." | 5.29 | Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. ( Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P, 1996) |
| "CSF levels of radioreceptorassayed endorphins Fraction I (EndFI, n = 92) and homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) (n = 118) were measured in patients with major depressive disorders according to Research Diagnostic Criteria (18% were psychotic; 11% hallucinated during the peak of the depressive episode)." | 3.67 | Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices. ( Agren, H; Terenius, L, 1985) |
| "26 patients with a paranoid-hallucinatory syndrome were treated with a fixed daily dose of haloperidol." | 3.65 | Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. ( Ackenheil, M; Eben, E; Hippius, H; Rüther, E; Schilkrut, R, 1976) |
| "In the patient group with visual hallucinations, mean salsolinol level was significantly increased to almost the 3-fold of those found in patients without hallucinations." | 1.29 | Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. ( Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PELICIER, Y | 1 |
| Gibson, KM | 1 |
| Gupta, M | 1 |
| Pearl, PL | 1 |
| Tuchman, M | 1 |
| Vezina, LG | 1 |
| Snead, OC | 1 |
| Smit, LM | 1 |
| Jakobs, C | 1 |
| Moser, A | 1 |
| Siebecker, F | 1 |
| Vieregge, P | 1 |
| Jaskowski, P | 1 |
| Kömpf, D | 1 |
| Billiard, M | 1 |
| Guilleminault, C | 1 |
| Dement, WC | 1 |
| Pieri, L | 1 |
| Keller, HH | 1 |
| Burkard, W | 1 |
| Da Prada, M | 1 |
| Rüther, E | 2 |
| Schilkrut, R | 2 |
| Ackenheil, M | 2 |
| Eben, E | 2 |
| Hippius, H | 2 |
| Perry, EK | 2 |
| Marshall, E | 2 |
| Kerwin, J | 2 |
| Smith, CJ | 1 |
| Jabeen, S | 2 |
| Cheng, AV | 1 |
| Perry, RH | 1 |
| McKeith, I | 1 |
| Thompson, P | 1 |
| Edwardson, JA | 1 |
| Ince, P | 1 |
| Blessed, G | 1 |
| Irving, D | 1 |
| Agren, H | 1 |
| Terenius, L | 1 |
| Roy, A | 1 |
| Nardoni, A | 1 |
| Di Piazza, V | 1 |
| Moretti, V | 1 |
| Copetti, R | 1 |
| Trinco, G | 1 |
| Fischer-Perroudon, C | 1 |
| Mouret, J | 1 |
| Jouvet, M | 1 |
| Vojtĕchovský, M | 1 |
| Vítek, V | 1 |
| Rysánek, K | 1 |
1 review available for hydroxyindoleacetic acid and Hallucinations
| Article | Year |
|---|---|
Depression, attempted suicide, and suicide in patients with chronic schizophrenia.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Atrophy; Brain; Chronic Disease; Del | 1986 |
1 trial available for hydroxyindoleacetic acid and Hallucinations
| Article | Year |
|---|---|
[Experimental psychosis after administration of benactyzine].
Topics: Benactyzine; Central Nervous System; Clinical Trials as Topic; Electroencephalography; Hallucination | 1966 |
12 other studies available for hydroxyindoleacetic acid and Hallucinations
| Article | Year |
|---|---|
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindole | 1964 |
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Topics: Adult; Aldehyde Oxidoreductases; Atrophy; Cerebellum; Chromatography, High Pressure Liquid; Chromato | 2003 |
Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Biomarkers; Catecholamines; Female; Hallucinations | 1996 |
A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
Topics: Adolescent; Disorders of Excessive Somnolence; Electroencephalography; Estrogens, Conjugated (USP); | 1975 |
Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
Topics: Animals; Brain; Cyclic AMP; Dopamine; Ergolines; Hallucinations; Homovanillic Acid; Humans; Hydroxyi | 1978 |
Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
Topics: Adult; Female; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac | 1976 |
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Topics: Acetylcholine; Aged; Aged, 80 and over; Autopsy; Biogenic Amines; Choline O-Acetyltransferase; Demen | 1990 |
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Hallucinatio | 1991 |
Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices.
Topics: Adult; Age Factors; Bipolar Disorder; Depressive Disorder; Endorphins; Female; Hallucinations; Homov | 1985 |
[Is serotonin implicated in the pathogenesis of the alcohol abstinence syndrome?].
Topics: Adult; Aged; Alcohol Withdrawal Delirium; Ethanol; Female; Hallucinations; Humans; Hydroxyindoleacet | 1989 |
[Case of agrypnia (4 months without sleep) in Morvan's disease. Favorable action of 5-hydroxytryptophan].
Topics: 5-Hydroxytryptophan; Adult; Chorea; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Ele | 1974 |